Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
11/2000
11/02/2000EP1048655A1 1,2-dihydro-2-oxoquinoline derivatives
11/02/2000EP1048652A1 Aromatic compounds having cyclic amino or salts thereof
11/02/2000EP1047692A1 Methods of synthesizing and screening inhibitors of bacterial nad synthetase enzyme, compounds thereof and methods of treating bacterial and microbial infections with these inhibitors
11/02/2000EP1047691A1 Quinolinepiperazine and quinolinepiperidine derivatives, their preparation and their use as combined 5-ht1a, 5-ht1b and 5-ht1d receptor antagonists
11/02/2000EP1047690A1 Heterocyclic ether and thioether compounds useful in controlling chemical synaptic transmission
11/02/2000EP1047689A1 Substituted guanidine derivatives
11/02/2000EP1047684A1 Substituted alpha,beta-anellated butyrolactones
11/02/2000EP1047678A1 1-substituted-1-aminomethyl-cycloalkane derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders
11/02/2000EP1047675A1 Chemokine receptor antagonists and methods of use therefor
11/02/2000EP1047673A1 Novel heterocyclic compounds
11/02/2000EP1047425A1 Integrin receptor antagonists
11/02/2000EP1047418A1 Inhibition of raf kinase using substituted heterocyclic ureas
11/02/2000EP0808312B1 Indole derivatives as 5-ht receptor antagonist
11/02/2000CA2371308A1 Tri-aryl acid derivatives as ppar receptor ligands
11/02/2000CA2371274A1 Selective npy (y5) antagonists
11/02/2000CA2370241A1 Tetrahydroisoquinolinyl-indole derivatives for the treatment of depression
11/02/2000CA2367695A1 Heteroaryl diazacycloalkanes, their preparation and use
11/01/2000CN1272108A Indole derivatives as 5-HT1B and 5-HT1D agonists
11/01/2000CN1058010C Novel quinoline carboxylic acid derivatives having 7-(4-aminomethyl-3-oxime) pyrrolidine substituent and process for preparing thereof
10/2000
10/31/2000US6140504 Substituted intermediate compounds for the preparation of n-[(aminoiminomethyl or aminomethyl)phenyl]propyl amides
10/31/2000US6140372 Acyl derivatives of melatonin and of melatoninergic analogues and their use as medicinal products
10/31/2000US6140361 For inhibiting binding of human immunodeficiency virus rev protein to rev responsive elements (rre)
10/31/2000US6140357 Small molecule inhibitors of rotamase enzyme activity
10/31/2000US6140352 Carbazolyl-substituted ethanolamines as selective β-3 agonists
10/31/2000US6140351 Ortho-anthranilamide derivatives as anti-coagulants
10/31/2000US6140349 Cyclic amine modulators of chemokine receptor activity
10/31/2000US6140345 For treating psychoses and pain
10/31/2000US6140344 For treating pathological conditions such as asthma, rhinitis, eczema and parasitic infections featuring tissue eosinophilia
10/31/2000US6140342 Cholesteryl ester transfer protein inhibitor; used to elevate certain plasma lipid levels, including high density lipoprotein-cholesterol and to lower certain other plasma lipid levels, such as ldl-cholesterol and triglycerides
10/31/2000US6140339 Monomeric and dimeric arylisoquinoline alkaloids and derivatives thereof
10/31/2000US6140338 For treating acute inflammatory diseases, chronic inflammatory diseases, acquired immune deficiency syndrome, cancer, ischemic reflow disorder and/or arteriosclerosis
10/31/2000US6140335 Use of mizolastine for treating inflammatory diseases associated with 5-lipoxygenase
10/26/2000WO2000063207A1 Pesticidal indazole or benzotriazole derivatives
10/26/2000WO2000063204A2 Substituted azoles
10/26/2000WO2000063203A1 Piperidine-indole compounds having 5-ht6 affinity
10/26/2000WO2000063186A1 Process and intermediates for preparing benzodiazepines
10/26/2000WO2000063183A1 Process for the preparation of substituted pyrimidines
10/26/2000WO2000063172A1 N-substituted piperidine derivatives
10/26/2000WO2000063171A1 Tricyclic compounds
10/26/2000WO2000063168A1 Synthesis of azetidine derivatives
10/26/2000WO2000063140A1 Template directed solid-state organic synthesis
10/26/2000WO2000062782A1 Novel synthesis and crystallization of piperazine ring-containing compounds
10/26/2000WO2000039082A3 1,2-annelated quinoline derivatives
10/26/2000WO2000035886A3 (hetero)aryl-bicyclic heteroaryl derivatives, their preparation and their use as protease inhibitors
10/26/2000WO2000035865A3 Tubulin-binding agents
10/26/2000WO2000021508A3 Novel therapeutic use of compounds with beta-3-agonist activity
10/26/2000WO2000004012A9 COMPOUNDS SPECIFIC FOR THE HUMAN α1d ADRENERGIC RECEPTOR AND USES THEREOF
10/26/2000DE19918211A1 New 2-carbocyclyl-benzimidazole-carboxamide derivatives, are PARP inhibitors useful e.g. for treating neurodegenerative disease, epilepsy, ischemia, tumors, inflammation or diabetes
10/26/2000CA2370417A1 Substituted azoles
10/26/2000CA2370285A1 Process for the preparation of substituted pyrimidines
10/26/2000CA2370265A1 Pesticidal indazole or benzotriazole derivatives
10/26/2000CA2368815A1 Novel synthesis and crystallization of piperazine ring-containing compounds
10/25/2000EP1045846A1 Imidazole derivatives having an inhibitory activity for farnesyl transferase and process for preparation thereof
10/25/2000EP1045845A1 N-oxides of heterocyclic compounds with tnf and pde-iv inhibiting activity
10/25/2000EP1045844A1 Inhibitors of farnesyl-protein transferase
10/25/2000EP1045843A1 Inhibitors of farnesyl-protein transferase
10/25/2000EP1045842A2 Methods of use and compositions for benzylidene- and cinnamylidene-anabaseines
10/25/2000EP1045839A2 Novel amines as pharmaceutical agents
10/25/2000EP1045837A1 Monomeric and dimeric arylisoquinoline alkaloids and derivatives thereof
10/25/2000EP1045836A1 Pyridones as src family sh2 domain inhibitors
10/25/2000EP1045835A1 Catalyst and method for amide formation
10/25/2000EP1045834A1 4(3)substituted-4(3)-aminomethyl-(thio)pyran or -piperidine derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders
10/25/2000EP1045833A1 2,3-substituted indole compounds as cox-2 inhibitors
10/25/2000EP1045693A1 Aminophenoxyacetic acid derivatives as neuroprotectants
10/25/2000EP0720601B1 Gastrin and cck receptor ligands
10/25/2000CN1271357A bisethers of 1-oxa, aza and thianaphthalen-2-ones as phospholamban inhibitors
10/25/2000CN1271355A Heterocyclic compounds and antitumor agent containing the same as active ingredient
10/25/2000CN1271354A Compounds possessing neuronal activity
10/25/2000CN1271349A Substituted quinazoline derivatives and their use as tyrosine kinase inhibitors
10/25/2000CN1271348A Method for producing (hetero) aromatic hydroxylamines
10/25/2000CN1271346A Method for producing substituted 2-nitroguanidine derivative
10/25/2000CN1271345A Method for producing substituted 2-nitroguanideine derivatives
10/25/2000CN1271284A Vitronectin receptor antagonist
10/25/2000CN1270959A 4-phenyl pyridine derivatives
10/24/2000US6137002 Glycoprotein IIb/IIIa antagonists
10/24/2000US6136844 5-aroylpyrrol-2-ylmethylarene derivatives
10/24/2000US6136834 Tetrazole compounds and pharmaceutical agents containing such derivative
10/24/2000US6136826 Aminopiperidine compounds substituted with alkanoyl
10/24/2000US6136823 Pyridonecarboxylic acid derivatives or salts thereof and drugs containing the same as the active ingredient
10/24/2000US6136822 Quinolinone derivative, method for preparing the same, and anti-allergic agent
10/24/2000US6136812 Methods of administering AMPA receptor antagonists to treat dyskinesias associated with dopamine agonist therapy
10/24/2000US6136800 Steroids
10/24/2000US6136344 Oral pharmaceutical dosage form
10/19/2000WO2000061608A2 Low-molecular inhibitors of complement proteases
10/19/2000WO2000061580A1 Substituted bicyclic heteroaryl compounds as integrin antagonists
10/19/2000WO2000061579A1 New endothelin converting enzyme inhibitors, their production and their use
10/19/2000WO2000061577A1 Prodrugs of thrombin inhibitors
10/19/2000WO2000061576A1 Triarylimidazoles
10/19/2000WO2000061575A1 Process for the production of indole derivatives and intermediates therefor
10/19/2000WO2000061564A1 Antiviral pyrimidinedione derivatives and process for the preparation thereof
10/19/2000WO2000061563A1 Antiviral pyrimidinedione derivatives and process for the preparation thereof
10/19/2000WO2000061562A1 Neurotrophic substituted pyrimidines
10/19/2000WO2000061561A1 Cyanoguanidine compounds
10/19/2000WO2000061551A2 Pyrimidine-2-one derivatives as integrin receptor ligands
10/19/2000WO2000061549A2 Pharmaceutical compounds
10/19/2000WO2000061541A2 Pharmaceutical compounds
10/19/2000WO2000061537A2 Pharmaceutical compounds
10/19/2000WO2000007996A8 Pyrazoles as estrogen receptor modulators
10/19/2000DE19917504A1 New hydroxy-indole derivatives, useful in treatment of degenerative joint disease, viral and parasitic infections, bronchial, dermatological, neurodegenerative and prostate disorders, etc.
10/19/2000DE19916719A1 Neue ECE-Inhibitoren, ihre Herstellung und Verwendung New ECE inhibitors, their preparation and use
1 ... 816 817 818 819 820 821 822 823 824 825 826 827 828 829 830 831 832 833 834 835 836 ... 1080